TITLE

Lactoferrin ameliorates prostaglandin E2-mediated inhibition of Na+-glucose cotransport in enterocytes

AUTHOR(S)
Talukder, Jamilur R.; Griffin, Ashley; Jaima, Antara; Boyd, Brittney; Wright, Jaleesa
PUB. DATE
January 2014
SOURCE
Canadian Journal of Physiology & Pharmacology;Jan2014, Vol. 92 Issue 1, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Various immunoinflammatory cytokines are produced during chronic intestinal inflammation, which inhibits Na+-glucose cotransport (SGLT1) in villus cells. Lactoferrin (Lf), abundantly present in colostrum, is a multifunctional glycoprotein that is absorbed by receptor-mediated transcytosis in humans and animals and has been shown to exert anti-inflammatory effects. Therefore, this study aimed to examine whether Lf would prevent PGE2 effect on SGLT1 for glucose absorption in enterocytes. Intestinal epithelial cells (IEC-6) were grown on transwell plates, treated with phlorizin, PGE2, AH6809, and Lf, and 3- O-methyl d-glucopyranose (OMG) uptake was measured in 10 days postconfluent. Na+-dependent OMG uptake, phlorizin, and immunoblotting studies established the activity and apical membrane localization of SGLT1 in IEC-6 cells. PGE2 inhibited SGLT1 in a concentration- and time-dependent manner with an inhibitory constant ( Ki) of 50.0 nmol/L and that was antagonized by prostanoid receptor inhibitor, AH6809. PGE2 did not alter Na+/K+-ATPase activity. In contrast, quantitative real-time polymerase chain reaction and Western blot analyses revealed that SGLT1-specific transcripts and protein expression level were decreased 3-fold by PGE2. Furthermore, PGE2 treatment increased intracellular cyclic adenosine monophosphate (cAMP) and Ca2+ concentrations and decreased SGLT1 expression on the apical membrane, and these effects were ameliorated by Lf. Therefore, we conclude that Lf ameliorates the PGE2 inhibition of SGLT1 most likely via the Ca2+- and cAMP-signaling pathways.
ACCESSION #
93433855

 

Related Articles

  • Role of Interleukin-21 in Inflammation and Allergy. Fina, Daniele; Fantini, Massimo Claudio; Pallone, Francesco; Monteleone, Giovanni // Inflammation & Allergy - Drug Targets;Jan2007, Vol. 6 Issue 1, p63 

    Interleukin-21 (IL-21) is a newly described cytokine, produced by activated CD4+ T cells. Since the discovery in 2000, IL-21 has been the object of intensive research because of its homology to IL-2, IL-4 and IL-15, and its ability to modulate both innate and adaptive immune responses. IL-21...

  • CXC and CC chemokine expression in inflamed and noninflamed pelvic ileal pouch tissue. Helwig, Ulf; Gionchetti, Paolo; Rizzello, Fernando; Lammers, Karen; Kühbacher, Tanja; Schreiber, Stefan; Baggiolini, Marco; Uguccioni, Mariagrazia; Campieri, Massimo // International Journal of Colorectal Disease;Mar2004, Vol. 19 Issue 2, p165 

    Background and aims. Pouchitis is the major long-term complication after ileal pouch–anal anastomosis (IPAA) in patients operated on for ulcerative colitis. The cause is unknown, but both the history of ulcerative colitis and increased bacterial concentration are important factors....

  • Fecal Eosinophil Granule-Derived Proteins Reflect Disease Activity in Inflammatory Bowel Disease. Saitoh, Osamu; Kojima, Keishi; Sugi, Kazunori; Matsuse, Ryoichi; Uchida, Kazuo; Tabata, Kazue; Nakagawa, Ken; Kayazawa, Masanobu; Hirata, Ichiro; Katsu, Ken-ichi // American Journal of Gastroenterology;Dec1999, Vol. 94 Issue 12, p3513 

    OBJECTIVES: The aims of this study were: 1) to examine whether the fecal levels of eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease (IBD); and 2) to examine the extracellular release of these proteins from eosinophils and their stability in feces by an...

  • ATL>Lactoferrin in whole gut lavage fluid as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Kayazawa, Masanobu; Saitoh, Osamu; Kojima, Keishi; Nakagawa, Ken; Tanaka, Seigou; Tabata, Kazue; Matsuse, Ryoichi; Uchida, Kazuo; Hoshimoto, Masahiro; Hirata, Ichiro; Katsu, Ken-ichi // American Journal of Gastroenterology;Feb2002, Vol. 97 Issue 2, p360 

    OBJECTIVES:We investigated which neutrophil-derived proteins in whole gut lavage fluid (WGLF) most accurately reflect disease activity in inflammatory bowel disease.METHODS:WGLF was obtained from patients undergoing whole gut lavage as a bowel preparation for colonoscopy. Twenty-seven patients...

  • Synbiotic therapy (Bifidobacterium Iongum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Furrie, E.; Macfarlane, S.; Kennedy, A.; Cummings, J. H.; Walsh, S. V.; O'neil, D. A.; Macfarlane, G. T. // Gut;Feb2005, Vol. 54 Issue 2, p242 

    Background and aims: Ulcerative colitis (UC) is an acute and chronic inflammatory disease of the large bowel with unknown aetiology. The immune response against normal commensal microorganisms is believed to drive inflammatory processes associated with UC. Therefore, modulation of bacterial...

  • Biologic response modifiers to decrease inflammation: Focus on infection risks. Saux, Nicole Le // Paediatrics & Child Health (1205-7088);Mar2012, Vol. 17 Issue 3, p147 

    Biologic response modifiers are a novel class of drugs used by sub-specialists to treat immune-mediated conditions such as juvenile idiopathic arthritis and inflammatory bowel disease. Also known as 'cytokine inhibitors', they are proteins whose purpose is to block the action of cytokines...

  • Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis. Wang Fan; Wang Maoqing; Chen Wangyang; Hu Fulan; Li Dandan; Ren Jiaojiao; Dong Xinshu; Cui Binbin; Zhao Yashuang // European Journal of Human Genetics;Apr2011, Vol. 19 Issue 4, p432 

    Inflammatory bowel disease (IBD) and colorectal cancer (CRC) are common health problems worldwide. Tumor necrosis factor (TNF) is a type of cytokine that induces inflammation and inhibits tumorigenesis. Several studies have assessed the relationship between the polymorphism of TNF-α-308 G>A...

  • Role of the CXC12-CXCR4 Axis and CXCL16 in Inflammatory Bowel Disease. Nakase, Hiroshi; Matsuura, Minoru; Mikami, Sakae; Uza, Norimitsu; Chiba, Tsutomu // Intestinal Research;2012, Vol. 10 Issue 2, p125 

    Numerous studies of colitis in IBD (inflammatory bowel diseases) patients and in animal models have demonstrated that both inflammatory cytokines and chemokines are up-regulated in settings of active inflammation. Blockade or absence of various cytokines and chemokines attenuates the disease in...

  • Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. Torres, M. I.; Riós, A.; A. Crusius, J. Bart // World Journal of Gastroenterology;4/7/2008, Vol. 14 Issue 13, p1972 

    Although the aetiology of inflammatory bowel disease (IBD) remains unknown, the pathogenesis is gradually being unravelled, seeming to be the result of a combination of environmental, genetic, and immunological factors in which an uncontrolled immune response within the intestinal lumen leads to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics